AD is characterized by two pathognomonic features: extracellular amyloid‐beta (Aβ) plaques aggregates and intraneuronal phosphorylated tau neurofibrillary tangle (NFT) inclusion bodies [2]. This evidence concerns the gene MAPT and Alzheimer disease.